BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21925906)

  • 1. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.
    De Nunzio C; Albisinni S; Freedland SJ; Miano L; Cindolo L; Finazzi Agrò E; Autorino R; De Sio M; Schips L; Tubaro A
    Urol Oncol; 2013 Oct; 31(7):997-1002. PubMed ID: 21925906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.
    De Nunzio C; Freedland SJ; Miano L; Finazzi Agrò E; Bañez L; Tubaro A
    Eur J Surg Oncol; 2011 Dec; 37(12):1025-9. PubMed ID: 21963050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: results from an Italian biopsy cohort.
    De Nunzio C; Albisinni S; Presicce F; Lombardo R; Cancrini F; Tubaro A
    Urol Oncol; 2014 Feb; 32(2):80-4. PubMed ID: 23153859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
    De Nunzio C; Lombardo R; Albisinni S; Gacci M; Tubaro A
    Int Braz J Urol; 2013; 39(6):793-9. PubMed ID: 24456771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy.
    Zilli T; Nguyen TV; Bahary JP; Chagnon M; Dufresne A; Taussky D
    Int J Obes (Lond); 2011 Nov; 35(11):1421-6. PubMed ID: 21266950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.
    Boehm K; Sun M; Larcher A; Blanc-Lapierre A; Schiffmann J; Graefen M; Sosa J; Saad F; Parent MÉ; Karakiewicz PI
    Urol Oncol; 2015 Nov; 33(11):494.e1-7. PubMed ID: 26278366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
    Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
    Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.
    Shiota M; Takeuchi A; Sugimoto M; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Tatsugami K; Yokomizo A
    Anticancer Res; 2015 Nov; 35(11):6137-45. PubMed ID: 26504040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
    De Nunzio C; Lombardo R; Leonardo C; Franco G; Gacci M; Presicce F; Cancrini F; Tubaro A
    Urol Oncol; 2014 Jan; 32(1):35.e9-13. PubMed ID: 23510864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage.
    Jentzmik F; Schnoeller TJ; Cronauer MV; Steinestel J; Steffens S; Zengerling F; Al Ghazal A; Schrader MG; Steinestel K; Schrader AJ
    Int J Urol; 2014 Oct; 21(10):980-6. PubMed ID: 24865433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
    Park J; Cho SY; Lee SB; Son H; Jeong H
    BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome increases the risk of aggressive prostate cancer detection.
    Morote J; Ropero J; Planas J; Bastarós JM; Delgado G; Placer J; Celma A; de Torres IM; Carles J; Reventós J; Doll A
    BJU Int; 2013 Jun; 111(7):1031-6. PubMed ID: 22883053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].
    Qu YY; Dai B; Chang K; Kong YY; Gu CY; Zhang GM; Wan FN; Wang HK; Zhang HL; Zhu Y; Ye DW
    Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1089-93. PubMed ID: 24499718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Schiavina R; Simonato A; Tubaro A; Mirone V; Carini M; Carmignani G
    Scand J Urol; 2014 Apr; 48(2):138-45. PubMed ID: 23781856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.